Caballero, J., Dávila, J., López-Pavía, M., Such, E., Bernal, T., Ramos, F., . . . Campelo, M. (2024). Outcomes and effect of somatic mutations after erythropoiesis stimulating agents in patients with lower-risk myelodysplastic syndromes.
Chicago Style CitationCaballero, JC, et al. Outcomes and Effect of Somatic Mutations After Erythropoiesis Stimulating Agents in Patients With Lower-risk Myelodysplastic Syndromes. 2024.
MLA CitationCaballero, JC, et al. Outcomes and Effect of Somatic Mutations After Erythropoiesis Stimulating Agents in Patients With Lower-risk Myelodysplastic Syndromes. 2024.
Warning: These citations may not always be 100% accurate.